Tenet Healthcare Corp (NYSE:THC) shares traded 0.8% up during most recent session to reach at the closing price of $17.62. The stock exchanged hands 3.64 Million shares versus average trading capacity of 3.85 Million shares, yielding a market cap of $1.78 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $19.73 within the next 52-weeks. The mean target projections are based on 13 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Tenet Healthcare Corp (NYSE:THC) high price target of $30 and with a conservative view have low price target of $14.

Leerink Swann “Maintained” Tenet Healthcare Corp (NYSE:THC) in a research note issued to investors on 8/21/17 to Outperform with price target of $30.

Additionally on 8/10/17 Deutsche Bank “Maintained” Tenet Healthcare Corp (NYSE:THC) to Buy setting price target at $24 and on 8/09/17 Credit Suisse “Maintained” the stock to Neutral at $17. Furthermore on 6/07/17 Morgan Stanley “Initiates Coverage On” the stock to Equal-Weight at $19.

On the other hand the company has Relative Strength Index (RSI 14) of 58.37 along with Average True Range (ATR 14) of 1, Consequently Tenet Healthcare Corp (NYSE:THC)’s weekly and monthly volatility is 4.79%, 5.94% respectively. The company’s beta value is at 1.29.

In terms of Buy, Sell or Hold recommendations, Tenet Healthcare Corp (NYSE:THC) has analysts’ mean recommendation of 2.5. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

According to analysts Tenet Healthcare Corp (NYSE:THC)’s minimum EPS for the current quarter is at $-0.85 and can go high up to $-0.21. The consensus mean EPS for the current quarter is at $-0.37 derived from a total of 14 estimates from the analysts who have weighed in on projected earnings. However the company reported $0.16 earnings per share for the same quarter during last year.

Previously Tenet Healthcare Corp (NYSE:THC) reported $-0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $-0.16 by $-0.01. The company posted an earnings surprise of -6.3%.

While considering growth estimates of the company, it has next quarter growth estimates of 2583.3% whereas during current quarter it has -331.2% estimations over growth, comparing to the estimations of -20.2% during current year and 59% for next year. Past 5 years growth of Tenet Healthcare Corp (NYSE:THC) observed at -14.72%, looking forward for the next 5 years it has a strong prediction of 25.24% over growth.

Tenet Healthcare Corp (NYSE:THC)’s revenue estimates for the current quarter are $4.7 Billion according to 11 number of analysts, for the current quarter the company has high revenue estimates of $4.78 Billion in contradiction of low revenue estimates of $4.6 Billion. For the current year the company’s revenue estimates are $19.26 Billion compared to low analyst estimates of $19.15 Billion and high estimates of $19.41 Billion according to 12 number of analysts.

Currently Tenet Healthcare Corp (NYSE:THC)’s shares owned by insiders are 2%, whereas shares owned by institutional owners are 0%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded 5.55%.

Tenet Healthcare Corp (NYSE:THC) 52-week high price stands at $24.86 and low price stands at $12.54, its price distance from 52-week high is -29.12% while its distance from 52-week low price is 40.51%. The stock hit its 52-week high on 09/07/16, and 52-week low on 08/17/17.

Tenet Healthcare Corp (NYSE:THC)’s trailing twelve month revenues are $19.32 Billion, whereas its price to sales ratio for the same period is 0.09. Its book value per share for the most recent quarter is $3.71 while its price to book ratio for the same period is 4.75, as for as the company’s cash per share for the most recent quarter is $4.71, however its price to cash per share ratio for the same period is 3.74. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.